Dimethylfumarate Is a Potent Inducer of Apoptosis in Human T Cells

Journal of Investigative Dermatology

Volumn 121, Issue 6, 2003, Pages 1383-1388

  Treumer, Felix ^a   Zhu, Kejian ^a,b   Gläser, Regine ^a   Mrowietz, Ulrich ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Fumaric acid esters; Psoriasis

Indexed keywords

APO2.7 PROTEIN; CD3 ANTIBODY; CD3 ANTIGEN; DIMETHYL SULFOXIDE; DNA FRAGMENT; FUMARIC ACID DERIVATIVE; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID ESTER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MEMBRANE PROTEIN; METHYLHYDROGENFUMARATE; OKT 3; PROTEIN; PROTEIN BCL 2; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FLOW CYTOMETRY; GERMANY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; NICK END LABELING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0345732760     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1747.2003.12605.x     Document Type: Article

References (33)

1. Altmeyer P, Matthes U, Pawlak F, et al: Antipsoriatic effect of fumaric acid derivatives: Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 30:977-981, 1994
2. Asadullah K, Schmid H, Friedrich M, et al: Influence of monomethylfumarate on monocytic cytokine formation-explanation for adverse and therapautic effects in psoriasis? Arch Dermatol Res 189:623-630, 1997
3. Bacharach-Buhles M, Pawlak FM, Matthes U, Joshi RK, Altmeyer P: Fumaric acid esters (FAEs) suppress CD 15-and ODP 4-positive cells in psoriasis. Acta Derm Venereol (Stockh) Suppl 186:79-82, 1994
4. Bureau F, Vanderplasschen A, Jaspar F, et al: Constitutive nuclear factor-kappaB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2 family proteins. Blood 99:3683-3691, 2002
5. Christophers E, Mrowietz U: Psoriasis. In: Freedberg IM, Eisen AZ, Wolff K, et al (eds). Psoriosis. Dermatology in General Medicine, 5th ed. New York: McGraw-Hill, 1999; p 495-521
6. Coven TR, Walters IB, Cardinale I, Krueger JG: PUVA-induced lymphocyte apoptosis: Mechanism of action in psoriasis. Photodermatol Photoimmunol Photemed 15:22-27, 1999
7. De Jong P, Bezemer AC, Zomerdijk TPL, Van de Pouw-Kraan T, Ottenhoff THM, Nibbering PH: Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur J Immunol 26:2067-2074, 1996
8. Ellis CN, Gorsulowski DC, Hamilton TA, et al: Cyclosporine improves psoriasis in a double-blind study. JAMA 256:3110-3116, 1986
9. Genestier L, Paillot R, Fournel S, Ferraro C, Miossec P, Revillard JP: Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest 102:322-328, 1998
10. Ghoreschi K, Thomas P, Breit S, et al: Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 9:40-46, 2003
11. Gudmundsdottir AS, Sigmundsdottir H, Sigurgeirsson B, Good MF, Valdimarsson H, Jonsdottir I: Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis? Clin Exp Immunol 117:580-586, 1999
12. Hildeman DA, Zhu Y, Mitchell TC, Kappler J, Marrack P: Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol 14:354-359, 2002
13. Höxtermann S, Nüchel C, Altmeyer P: Fumaric acid esters suppress peripheral CD4-and CD8-positive lymphocytes in psoriasis. Dermatology 196:223-230, 1998
14. Kolenko V, Bloom T, Rayman P, Bukowski R, Hsi E, Finke J: Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J Immunol 163:590-598, 1999
15. Loewe R, Holnthoner W, Groger M, et al: Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappaB/p65 in human endothelial cells. J Immunol 168:4781-4787, 2002
16. Loewe R, Pillinger M, de Martin R, et al: Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner. J Invest Dermatol 117:1363-1368, 2001
17. Marsden VS, Strasser A: Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 21:71-105, 2003
18. Mrowietz U, Christophers E, Altmeyer P: Treatment of psoriasis with fumaric acid esters: Results of a prospective multicenter study. Br J Dermatol 138:456-460, 1997
19. Mrowietz U, Christophers E, Altmeyer P: Treatment of severe psoriasis with fumaric acid esters: Scientific background and guidelines for therapeutic use. Br J Dermatol 141:424-429, 1999
20. Nagahara Y, Ikekita M, Shinomiya T: T cell selective apoptosis by a novel immunosuppressant, FTY720. is closely regulated with Bcl-2. Br J Pharmacol 137:953-962, 2002
21. Nicholas JF, Chamchick N, Thivolet J, Wijdenes J, Morel P, Reveillard JP: CD4 antibody treatment of severe psoriasis. Lancet 338:321, 1991
22. Prinz JC: Psoriasis vulgaris - A sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis. Clin Exp Dermatol 26:326-332, 2001
23. Prinz J, Braun Falco O, Meurer M, Daddona P, Reiter C, Rieber P, Riethmuller G: Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis [letter]. Lancet 338:320-321, 1991
24. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P: Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 188:2175-2180, 1998
25. Schweckendiek W: Heilung von Psoriasis. Med Monatschr 13:103-104, 1959
26. Sebök B, Mahrle G, Gollnick H, Bonnekoh B: Dimethylfumarat ist unter den Fumaderm®-Inhaltsstoffen der stärkste Induktor von Apoptose-Phänomenen in lympho-histiozytären U-937-Zellen. Z Hautkrankheiten H+G 75:1-5, 2000
27. Stoof TJ, Flier J, Sampat S, Nieboer C, Tensen CP, Boorsma DM: The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells. Br J Dermatol 144:1114-1120, 2001
28. Suzuki S, Li XK, Enosawa S, Shinomiya T: A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunol 89:518-523, 1996
29. Vandermeeren M, Janssens S, Boergers M, Geysen J: Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-1, and ICAM-I expression in human endothelial cells. Biochem Biophys Res Commun 234:19-23, 1997
30. Vandermeeren M, Janssens S, Wouters H, Borghmans I, Borgers M, Beyaert R, Geysen J: Dimethylfumarate is an inhibitor of cytokine-induced nuclear translocation of NF-kappa B1, but not RelA in normal human dermal fibroblast cells. J Invest Dermatol 116:124-130, 2001
31. Vollmer S, Menssen A, Prinz JC: Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from nonlesional skin: Evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris. J Invest Dermatol 117:1296-1301, 2001
32. Zhang C, Ao Z, Seth A, Schlossman SF: A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol 157:3980-3987, 1996
33. Zhu K, Mrowietz U: Inhibition of dendritic cell differentiation by fumaric acid esters. J Invest Dermatol 116:203-208, 2001